Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-03

FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Glucagon submitted by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)

Snippet

SUPPL AP for GLUCAGON (GLUCAGON)